What Craig Barratt’s appointment really says about Intel’s next strategic chapter
Intel Corporation appoints Dr. Craig Barratt as chairman replacing Frank Yeary. Discover what the governance shift means for Intel’s turnaround and semiconductor competition.
Can Banco Santander still complete its takeover of Webster Financial amid geopolitical tensions?
Wells Fargo downgrades Webster Financial (NYSE: WBS) after Trump’s Spain stance raises uncertainty around Santander’s takeover. Read the full strategic analysis.
HIMS near 52-week low as FDA issues 30 GLP-1 warning letters
FDA sends 30 warning letters to GLP-1 compounders, targeting Hims & Hers Health (HIMS) as regulatory and legal pressure intensifies. Read what it means for investors and the sector.
A small deal with strategic implications: Can Scandium Canada turn Crater Lake into a scandium supply hub?
Scandium Canada Ltd launches a C$10M bought deal financing to advance its Crater Lake project and aluminum-scandium alloy strategy. Read the full analysis.
Kraken Robotics Inc. announces $615m Covelya Group acquisition to scale global underwater technology business
Kraken Robotics Inc. plans a $615M Covelya acquisition and $350M capital raise to expand subsea robotics technology. Find out what this means for maritime tech markets.
Is Four Corners Property Trust quietly building a defensive auto service moat in Texas?
Four Corners Property Trust (NYSE: FCPT) buys a $1.6M Texas auto service property. Discover what this means for its net-lease growth strategy.
Why Scholar Rock believes apitegromab could still become a major SMA therapy despite FDA delays
Scholar Rock targets a 2026 BLA resubmission and potential launch for apitegromab in spinal muscular atrophy. Discover what it means for the SMA market.
Vanda Pharmaceuticals (VNDA) wins FDA’s first formal drug approval hearing in 40 years as Hetlioz jet lag battle enters new phase
FDA grants Vanda Pharmaceuticals a rare Part 12 public hearing on Hetlioz jet lag rejection, the first such drug approval hearing in 40 years. Read the full analysis.
What Semtech Corporation’s $34m HieFo Corporation acquisition reveals about the future of optical interconnects
Semtech Corporation acquires HieFo Corporation for $34M to expand optical networking for AI data centers. Discover why the deal signals a shift in semiconductor strategy.
What Moderna Inc.’s settlement with Arbutus Biopharma Corporation means for the future of mRNA medicines
Moderna stock surged after hours after settling a $2.25B patent dispute with Arbutus Biopharma and Genevant Sciences. Discover what it means for mRNA vaccines.